ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,908Medicare Part D Prescriptions Filled, Including Refills

Rank: 371 out of 2588

$590K Total Retail Price of All Prescriptions

Rank: 342 out of 2588

391 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Illinois
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 391 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

18% of this provider’s 391 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 8,418 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Illinois
WARFARIN SODIUM 414 408 1 10
LEVOTHYROXINE SODIUM 338 310 2 2
FUROSEMIDE 324 307 3 5
SIMVASTATIN 321 287 4 1
AMLODIPINE BESYLATE 310 276 5 4
OMEPRAZOLE 271 208 6 6
HYDROCODONE-ACETAMINOPHEN 264 226 S3 7 7
LISINOPRIL 241 226 8 3
METOPROLOL TARTRATE 200 169 9 9
PANTOPRAZOLE SODIUM 170 155 10 28
DONEPEZIL HCL 154 138 11 22
METFORMIN HCL 153 117 12 8
POTASSIUM CHLORIDE 141 126 13 15
NAMENDA 140 125 14 32
FENOFIBRATE 106 89 15 64
GABAPENTIN 103 103 16 18
CITALOPRAM HBR 94 71 17 27
DIOVAN 90 71 18 29
METOPROLOL SUCCINATE 89 74 19 12
HYDROCHLOROTHIAZIDE 89 82 19 13
CARVEDILOL 84 78 21 20
ATENOLOL 83 83 22 14
ENALAPRIL MALEATE 78 70 23 31
GLIMEPIRIDE 78 60 23 39
KLOR-CON M20 77 75 25 52
SPIRIVA 76 67 26 56
PREDNISONE 75 58 27 42
TRAMADOL HCL 74 55 28 19
ALBUTEROL SULFATE 73 61 29 116
ATORVASTATIN CALCIUM 70 70 30 11
LIDODERM 70 47 30 86
PRAVASTATIN SODIUM 68 66 32 16
ALLOPURINOL 68 55 32 33
POLYETHYLENE GLYCOL 3350 68 54 32 55
RANITIDINE HCL 67 66 35 37
CLOPIDOGREL 66 65 36 30
FENTANYL 64 40 S2 37 78
CLONIDINE HCL 64 50 37 54
ALENDRONATE SODIUM 63 56 39 21
DIGOXIN 63 60 39 38
PLAVIX 62 62 41 43
LOSARTAN POTASSIUM 59 55 42 17
NAPROXEN 58 40 43 95
RISPERIDONE 56 48 44 57
GLIPIZIDE 55 32 45 44
RAMIPRIL 55 55 45 111
ADVAIR DISKUS 55 38 45 48
SERTRALINE HCL 54 46 48 26
CYMBALTA 53 28 49 70
ISOSORBIDE MONONITRATE ER 51 51 50 49
LANTUS SOLOSTAR 50 50 51 93
HYDRALAZINE HCL 50 50 51 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.